Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis.
Demierre
Marie-France
MF
Ferzli
Pascal
P
Miller
Donald
D
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D016588:Anticarcinogenic Agents / Q000008:administration & dosage; D000077610:Bexarotene; D005260:Female; D006304:Health Status; D006305:Health Status Indicators; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000523:psychology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D017893:Photopheresis; D010865:Pilot Projects; D011788:Quality of Life; D012878:Skin Neoplasms / Q000523:psychology / Q000628:therapy*; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage
D016588:Anticarcinogenic Agents; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene